The global oral solid dosage pharmaceutical formulation industry is on track for a stellar performance, with a projected Compound Annual Growth Rate (CAGR) of 6.4% from 2022 to 2032. This translates to a market value reaching a staggering US$ 1.0 billion by 2032, compared to an estimated US$ 555.3 million in 2022. This significant growth …